{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T22:53:03Z","timestamp":1792882383228,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T00:00:00Z","timestamp":1607644800000},"content-version":"vor","delay-in-days":10,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81470543; 81774295"],"award-info":[{"award-number":["81470543; 81774295"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81873296"],"award-info":[{"award-number":["81873296"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Diabetic cardiomyopathy is a main cause of the increased morbidity in diabetic patients, no effective treatment is available so far. Polydatin, a resveratrol glucoside isolated from the\n                      <jats:italic>Polygonum cuspidatum<\/jats:italic>\n                      , was found by our and others have antioxidant and cardioprotective activities. Therapeutic effects of polydatin on diabetic cardiomyopathy and the possible mechanisms remains unclear. This study aimed to investigate the cardioprotective effects and underlying mechanisms of polydatin on myocardial injury induced by hyperglycemia.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Diabetes in rats was made by high-fat diet combined with multiple low doses of streptozotocin, and then treated with polydatin (100\u2009mg\u00b7kg-1\u00b7day-1, by gavage) for 8\u2009weeks. Cardiac function was examined by echocardiography. Myocardial tissue and blood samples were collected for histology, protein and metabolic characteristics analysis. In cultured H9c2 cells with 30\u2009mM of glucose, the direct effects of polydatin on myocyte injury were also observed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In diabetic rats, polydatin administration significantly improved myocardial dysfunction and attenuated histological abnormalities, as evidenced by elevating left ventricular shortening fraction and ejection fraction, as well as reducing cardiac hypertrophy and interstitial fibrosis. In cultured H9c2 cells, pretreatment of polydatin dose-dependently inhibited high glucose-induced cardiomyocyte injury. Further observation evidenced that polydatin suppressed the increase in the reactive oxygen species levels, NADPH oxidase activity and inflammatory cytokines production induced by hyperglycemia in vivo and in vitro. Polydatin also prevented the increase expression of NOX4, NOX2 and NF-\u03baB in the high glucose -stimulated H9c2 cells and diabetic hearts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our results demonstrate that the cardioprotective effect of polydatin against hyperglycemia-induced myocardial injury is mediated by inhibition of NADPH oxidase and NF-\u03baB activity. The findings may provide a novel understanding the mechanisms of the polydatin to be a potential treatment of diabetic cardiomyopathy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12906-020-03177-y","type":"journal-article","created":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T08:04:58Z","timestamp":1607673898000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Cardioprotective effects of polydatin against myocardial injury in diabetic rats via inhibition of NADPH oxidase and NF-\u03baB activities"],"prefix":"10.1186","volume":"20","author":[{"given":"Ying-Ying","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei-Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9594-1991","authenticated-orcid":false,"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,11]]},"reference":[{"issue":"4","key":"3177_CR1","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1007\/s00125-014-3171-6","volume":"57","author":"H Bugger","year":"2014","unstructured":"Bugger H, Abel ED. Molecular mechanisms of diabetic cardiomyopathy. Diabetologia. 2014;57(4):660\u201371.","journal-title":"Diabetologia"},{"issue":"4","key":"3177_CR2","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","volume":"122","author":"G Jia","year":"2018","unstructured":"Jia G, Hill MA, Sowers JR. Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity. Circ Res. 2018;122(4):624\u201338.","journal-title":"Circ Res"},{"issue":"3","key":"3177_CR3","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.hfc.2019.02.003","volume":"15","author":"S Paolillo","year":"2019","unstructured":"Paolillo S, Marsico F, Prastaro M, Renga F, Esposito L, De Martino F, Di Napoli P, Esposito I, Ambrosio A, Ianniruberto M, Mennella R, Paolillo R, Gargiulo P. Diabetic cardiomyopathy: definition, diagnosis, and therapeutic implications. Heart Fail Clin. 2019;15(3):341\u20137.","journal-title":"Heart Fail Clin"},{"issue":"5 Pt B","key":"3177_CR4","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1016\/j.bbadis.2017.07.025","volume":"1864","author":"SS Hansen","year":"2018","unstructured":"Hansen SS, Aasum E, Hafstad AD. The role of NADPH oxidases in diabetic cardiomyopathy. Biochim Biophys Acta Mol Basis Dis. 2018;1864(5 Pt B):1908\u201313.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"4","key":"3177_CR5","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1136\/heartjnl-2017-311448","volume":"104","author":"AJ Wilson","year":"2018","unstructured":"Wilson AJ, Gill EK, Abudalo RA, Edgar KS, Watson CJ, Grieve DJ. Reactive oxygen species signalling in the diabetic heart: emerging prospect for therapeutic targeting. Heart. 2018;104(4):293\u20139.","journal-title":"Heart"},{"key":"3177_CR6","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3389\/fphys.2018.00114","volume":"9","author":"A Sharma","year":"2018","unstructured":"Sharma A, Tate M, Mathew G, Vince JE, Ritchie RH, de Haan JB. Oxidative stress and NLRP3-Inflammasome activity as significant drivers of diabetic cardiovascular complications: therapeutic implications. Front Physiol. 2018;9:114.","journal-title":"Front Physiol"},{"issue":"10","key":"3177_CR7","doi-asserted-by":"publisher","first-page":"25234","DOI":"10.3390\/ijms161025234","volume":"16","author":"Y Kayama","year":"2015","unstructured":"Kayama Y, Raaz U, Jagger A, Adam M, Schellinger IN, Sakamoto M, Suzuki H, Toyama K, Spin JM, Tsao PS. Diabetic cardiovascular disease induced by oxidative stress. Int J Mol Sci. 2015;16(10):25234\u201363.","journal-title":"Int J Mol Sci"},{"key":"3177_CR8","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3389\/fendo.2017.00072","volume":"8","author":"PK Mishra","year":"2017","unstructured":"Mishra PK, Ying W, Nandi SS, Bandyopadhyay GK, Patel KK, Mahata SK. Diabetic cardiomyopathy: an Immunometabolic perspective. Front Endocrinol (Lausanne). 2017;8:72.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"3177_CR9","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.bbadis.2014.05.006","volume":"1852","author":"L Yang","year":"2015","unstructured":"Yang L, Zhao D, Ren J, Yang J. Endoplasmic reticulum stress and protein quality control in diabetic cardiomyopathy. Biochim Biophys Acta. 2015;1852(2):209\u201318.","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"3177_CR10","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1016\/j.ijcard.2013.07.150","volume":"168","author":"X Palomer","year":"2013","unstructured":"Palomer X, Salvad\u00f3 L, Barroso E, V\u00e1zquez-Carrera M. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy. Int J Cardiol. 2013;168(4):3160\u201372.","journal-title":"Int J Cardiol"},{"issue":"5","key":"3177_CR11","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/j.1463-1326.2011.01369.x","volume":"13","author":"ND Roe","year":"2011","unstructured":"Roe ND, Thomas DP, Ren J. Inhibition of NADPH oxidase alleviates experimental diabetes-induced myocardial contractile dysfunction. Diabetes Obes Metab. 2011;13(5):465\u201373.","journal-title":"Diabetes Obes Metab"},{"issue":"9","key":"3177_CR12","first-page":"10908","volume":"8","author":"Y Liu","year":"2015","unstructured":"Liu Y, Zhang J. Nox2 contributes to cardiac fibrosis in diabetic cardiomyopathy in a transforming growth factor-\u03b2 dependent manner. Int J Clin Exp Pathol. 2015;8(9):10908\u201314.","journal-title":"Int J Clin Exp Pathol"},{"issue":"3","key":"3177_CR13","doi-asserted-by":"publisher","first-page":"C597","DOI":"10.1152\/ajpcell.00331.2011","volume":"302","author":"RM Maalouf","year":"2012","unstructured":"Maalouf RM, Eid AA, Gorin YC, Block K, Escobar GP, Bailey S, Abboud HE. Nox4-derived reactive oxygen species mediate cardiomyocyte injury in early type 1 diabetes. Am J Physiol Cell Physiol. 2012;302(3):C597\u2013604.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"7","key":"3177_CR14","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1161\/CIRCULATIONAHA.114.011079","volume":"131","author":"QD Zhao","year":"2015","unstructured":"Zhao QD, Viswanadhapalli S, Williams P, Shi Q, Tan C, Yi X, Bhandari B, Abboud HE. NADPH oxidase 4 induces cardiac fibrosis and hypertrophy through activating Akt\/mTOR and NF\u03baB signaling pathways. Circulation. 2015;131(7):643\u201355.","journal-title":"Circulation"},{"issue":"7","key":"3177_CR15","doi-asserted-by":"publisher","first-page":"H1036","DOI":"10.1152\/ajpheart.00340.2014","volume":"307","author":"CM Thomas","year":"2014","unstructured":"Thomas CM, Yong QC, Rosa RM, Seqqat R, Gopal S, Casarini DE, Jones WK, Gupta S, Baker KM, Kumar R. Cardiac-specific suppression of NF-\u03baB signaling prevents diabetic cardiomyopathy via inhibition of the renin-angiotensin system. Am J Physiol Heart Circ Physiol. 2014;307(7):H1036\u201345.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"3177_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.106","volume":"8","author":"MX Zhao","year":"2017","unstructured":"Zhao MX, Zhou B, Ling L, Xiong XQ, Zhang F, Chen Q, Li YH, Kang YM, Zhu GQ. Salusin-\u03b2 contributes to oxidative stress and inflammation in diabetic cardiomyopathy. Cell Death Dis. 2017;8(3):e2690.","journal-title":"Cell Death Dis"},{"key":"3177_CR17","doi-asserted-by":"publisher","unstructured":"Fiordelisi A, Iaccarino G, Morisco C, Coscioni E, Sorriento D. NFkappaB is a key player in the crosstalk between inflammation and cardiovascular diseases. Int J Mol Sci. 2019;20(7):1599. https:\/\/doi.org\/10.3390\/ijms20071599.","DOI":"10.3390\/ijms20071599"},{"issue":"3","key":"3177_CR18","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/cvr\/cvp305","volume":"85","author":"N Mariappan","year":"2010","unstructured":"Mariappan N, Elks CM, Sriramula S, Guggilam A, Liu Z, Borkhsenious O, Francis J. NF-kappaB-induced oxidative stress contributes to mitochondrial and cardiac dysfunction in type II diabetes. Cardiovasc Res. 2010;85(3):473\u201383.","journal-title":"Cardiovasc Res"},{"issue":"2","key":"3177_CR19","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.bbadis.2014.06.030","volume":"1852","author":"ZV Varga","year":"2015","unstructured":"Varga ZV, Giricz Z, Liaudet L, Hask\u00f3 G, Ferdinandy P, Pacher P. Interplay of oxidative, nitrosative\/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathy. Biochim Biophys Acta. 2015;1852(2):232\u201342.","journal-title":"Biochim Biophys Acta"},{"key":"3177_CR20","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.3389\/fphys.2018.01514","volume":"9","author":"G Borghetti","year":"2018","unstructured":"Borghetti G, von Lewinski D, Eaton DM, Sourij H, Houser SR, Wallner M. Diabetic cardiomyopathy: current and future therapies. Beyond Glycemic Control. Front Physiol. 2018;9:1514.","journal-title":"Front Physiol"},{"issue":"11","key":"3177_CR21","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.3109\/13880209.2013.792849","volume":"51","author":"QH Du","year":"2013","unstructured":"Du QH, Peng C, Zhang H. Polydatin: a review of pharmacology and pharmacokinetics. Pharm Biol. 2013;51(11):1347\u201354.","journal-title":"Pharm Biol"},{"issue":"6","key":"3177_CR22","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1039\/C6FO01842D","volume":"8","author":"D Ming","year":"2017","unstructured":"Ming D, Songyan L, Yawen C, Na Z, Jing M, Zhaowen X, Ye L, Wa D, Jie L. trans-Polydatin protects the mouse heart against ischemia\/reperfusion injury via inhibition of the renin-angiotensin system (RAS) and rho kinase (ROCK) activity. Food Funct. 2017;8(6):2309\u201321.","journal-title":"Food Funct"},{"key":"3177_CR23","doi-asserted-by":"crossref","first-page":"2750695","DOI":"10.1155\/2018\/2750695","volume":"2018","author":"L Yu","year":"2018","unstructured":"Yu L, Li Z, Dong X, Xue X, Liu Y, Xu S, Zhang J, Han J, Yang Y, Wang H. Polydatin protects diabetic heart against ischemia-reperfusion injury via Notch1\/Hes1-mediated activation of Pten\/Akt signaling. Oxidative Med Cell Longev. 2018;2018:2750695.","journal-title":"Oxidative Med Cell Longev"},{"issue":"18","key":"3177_CR24","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1042\/CS20160082","volume":"130","author":"Y Ling","year":"2016","unstructured":"Ling Y, Chen G, Deng Y, Tang H, Ling L, Zhou X, Song X, Yang P, Liu Y, Li Z, Zhao C, Yang Y, Wang X, Kitakaze M, Liao Y, Chen A. Polydatin post-treatment alleviates myocardial ischaemia\/reperfusion injury by promoting autophagic flux. Clin Sci (Lond). 2016;130(18):1641\u201353.","journal-title":"Clin Sci (Lond)"},{"key":"3177_CR25","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.freeradbiomed.2013.02.030","volume":"60","author":"X Jiang","year":"2013","unstructured":"Jiang X, Liu W, Deng J, Lan L, Xue X, Zhang C, Cai G, Luo X, Liu J. Polydatin protects cardiac function against burn injury by inhibiting sarcoplasmic reticulum Ca2+ leak by reducing oxidative modification of ryanodine receptors. Free Radic Biol Med. 2013;60:292\u20139.","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"3177_CR26","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1016\/j.bbrc.2017.09.151","volume":"493","author":"M Zhang","year":"2017","unstructured":"Zhang M, Wang S, Cheng Z, Xiong Z, Lv J, Yang Z, Li T, Jiang S, Gu J, Sun D, Fan Y. Polydatin ameliorates diabetic cardiomyopathy via Sirt3 activation. Biochem Biophys Res Commun. 2017;493(3):1280\u20137.","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"3177_CR27","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1177\/1535370214561958","volume":"240","author":"Q Zhang","year":"2015","unstructured":"Zhang Q, Tan Y, Zhang N, Yao F. Polydatin prevents angiotensin II-induced cardiac hypertrophy and myocardial superoxide generation. Exp Biol Med (Maywood). 2015;240(10):1352\u201361.","journal-title":"Exp Biol Med (Maywood)"},{"key":"3177_CR28","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3892\/mmr.2014.2708","volume":"11","author":"Q Zhang","year":"2015","unstructured":"Zhang Q, Tan Y, Zhang N, Yao F. Polydatin ameliorates diet-induced development of insulin resistance and hepatic steatosis in rats. Mol Med Report. 2015;11:603\u201310.","journal-title":"Mol Med Report"},{"issue":"21","key":"3177_CR29","first-page":"4256","volume":"40","author":"B Huang","year":"2015","unstructured":"Huang B, Xue L, Wu Y, Jiang QS. Effect and mechanism of Polydatin on diabetic myocardial hypertrophy in mice. Zhongguo Zhong Yao Za Zhi. 2015;40(21):4256\u201361.","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"3177_CR30","doi-asserted-by":"publisher","unstructured":"Zhang M, Lv XY, Li J, Xu ZG, Chen L. The characterization of high-fat diet and multiple low-dose streptozotocin induced type 2 diabetes rat model. Exp Diabetes Res. 2008;2008:704045. https:\/\/doi.org\/10.1155\/2008\/704045.","DOI":"10.1155\/2008\/704045"},{"key":"3177_CR31","doi-asserted-by":"crossref","first-page":"7092140","DOI":"10.1155\/2018\/7092140","volume":"2018","author":"Y Wang","year":"2018","unstructured":"Wang Y, La X, Tian C, et al. Effects of modified Sanzi Yangqin decoction on tyrosine phosphorylation of IRS-1 in skeletal muscle of type 2 diabetic rats. Evid Based Complement Alternat Med. 2018;2018:7092140.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"8","key":"3177_CR32","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.3889\/oamjms.2019.218","volume":"7","author":"S Syafril","year":"2019","unstructured":"Syafril S, Lindarto D, Lelo A, Sembiring RJ, Saragih A. Correlations between insulin receptor Substrate-1 with Phosphoinositide 3-kinase and P38 mitogen-activated protein kinase levels after treatment of diabetic rats with Puguntano (Curanga Fel-terrae [Merr.]) leaf extract. Open Access Maced J Med Sci. 2019;7(8):1247\u201351.","journal-title":"Open Access Maced J Med Sci"},{"issue":"4","key":"3177_CR33","doi-asserted-by":"publisher","first-page":"H802","DOI":"10.1152\/ajpheart.00093.2018","volume":"315","author":"G Li","year":"2018","unstructured":"Li G, Xing W, Zhang M, Geng F, Yang H, Zhang H, Zhang X, Li J, Dong L, Gao F. Antifibrotic cardioprotection of berberine via downregulating myocardial IGF-1 receptor-regulated MMP-2\/MMP-9 expression in diabetic rats. Am J Physiol Heart Circ Physiol. 2018;315(4):H802\u201313.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"3177_CR34","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ejphar.2014.09.047","volume":"745","author":"J Hao","year":"2014","unstructured":"Hao J, Chen C, Huang K, Huang J, Li J, Liu P, Huang H. Polydatin improves glucose and lipid metabolism in experimental diabetes through activating the Akt signaling pathway. Eur J Pharmacol. 2014;745:152\u201365.","journal-title":"Eur J Pharmacol"},{"key":"3177_CR35","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12933-015-0325-x","volume":"15","author":"Y Wang","year":"2016","unstructured":"Wang Y, Ye J, Li J, Chen C, Huang J, Liu P, Huang H. Polydatin ameliorates lipid and glucose metabolism in type 2 diabetes mellitus by downregulating proprotein convertase subtilisin\/kexin type 9 (PCSK9). Cardiovasc Diabetol. 2016;15:19.","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"3177_CR36","doi-asserted-by":"publisher","first-page":"815","DOI":"10.3892\/mmr.2012.1015","volume":"6","author":"J Zhang","year":"2012","unstructured":"Zhang J, Tan Y, Yao F, Zhang Q. Polydatin alleviates non-alcoholic fatty liver disease in rats by inhibiting the expression of TNF-\u03b1 and SREBP-1c. Mol Med Rep. 2012;6(4):815\u201320.","journal-title":"Mol Med Rep"},{"key":"3177_CR37","first-page":"7196535","volume":"2019","author":"L Zheng","year":"2019","unstructured":"Zheng L, Wu J, Mo J, Guo L, Wu X, Bao Y. Polydatin inhibits adipose tissue inflammation and ameliorates lipid metabolism in high-fat-fed mice. Biomed Res Int. 2019;2019:7196535.","journal-title":"Biomed Res Int"},{"key":"3177_CR38","doi-asserted-by":"publisher","first-page":"6605","DOI":"10.12659\/MSM.914877","volume":"25","author":"N Jin","year":"2019","unstructured":"Jin N, Wang Y, Liu L, Xue F, Jiang T, Xu M. Dysregulation of the renin-angiotensin system and Cardiometabolic status in mice fed a long-term high-fat diet. Med Sci Monit. 2019;25:6605\u201314.","journal-title":"Med Sci Monit"},{"issue":"11","key":"3177_CR39","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1053\/meta.2000.17721","volume":"49","author":"MJ Reed","year":"2000","unstructured":"Reed MJ, Meszaros K, Entes LJ, Claypool MD, Pinkett JG, Gadbois TM, Reaven GM. A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism. 2000;49(11):1390\u20134.","journal-title":"Metabolism"},{"issue":"4","key":"3177_CR40","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/jdi.12235","volume":"5","author":"S Skovs\u00f8","year":"2014","unstructured":"Skovs\u00f8 S. Modeling type 2 diabetes in rats using high fat diet and streptozotocin. J Diabetes Investig. 2014;5(4):349\u201358.","journal-title":"J Diabetes Investig"},{"key":"3177_CR41","doi-asserted-by":"publisher","unstructured":"Fang JY, Lin CH, Huang TH, Chuang SY. In Vivo Rodent Models of Type 2 Diabetes and Their Usefulness for Evaluating Flavonoid Bioactivity. Nutrients. 2019;11(3):530. https:\/\/doi.org\/10.3390\/nu11030530.","DOI":"10.3390\/nu11030530"},{"issue":"11","key":"3177_CR42","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1161\/CIRCRESAHA.116.306923","volume":"118","author":"MS Shah","year":"2016","unstructured":"Shah MS, Brownlee M. Molecular and cellular mechanisms of cardiovascular disorders in diabetes. Circ Res. 2016;118(11):1808\u201329.","journal-title":"Circ Res"},{"issue":"2","key":"3177_CR43","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s10741-018-9749-1","volume":"24","author":"B Parim","year":"2019","unstructured":"Parim B, Sathibabu Uddandrao VV, Saravanan G. Diabetic cardiomyopathy: molecular mechanisms, detrimental effects of conventional treatment, and beneficial effects of natural therapy. Heart Fail Rev. 2019;24(2):279\u201399.","journal-title":"Heart Fail Rev"},{"issue":"35","key":"3177_CR44","doi-asserted-by":"publisher","first-page":"15565","DOI":"10.1073\/pnas.1002178107","volume":"107","author":"J Kuroda","year":"2010","unstructured":"Kuroda J, Ago T, Matsushima S, Zhai P, Schneider MD, Sadoshima J. NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart. Proc Natl Acad Sci U S A. 2010;107(35):15565\u201370.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3177_CR45","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.freeradbiomed.2017.03.003","volume":"106","author":"W Gong","year":"2017","unstructured":"Gong W, Li J, Chen Z, Huang J, Chen Q, Cai W, Liu P, Huang H. Polydatin promotes Nrf2-ARE anti-oxidative pathway through activating CKIP-1 to resist HG-induced up-regulation of FN and ICAM-1 in GMCs and diabetic mice kidneys. Free Radic Biol Med. 2017;106:393\u2013405.","journal-title":"Free Radic Biol Med"},{"key":"3177_CR46","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.fct.2016.07.032","volume":"96","author":"QH Meng","year":"2016","unstructured":"Meng QH, Liu HB, Wang JB. Polydatin ameliorates renal ischemia\/reperfusion injury by decreasing apoptosis and oxidative stress through activating sonic hedgehog signaling pathway. Food Chem Toxicol. 2016;96:215\u201325.","journal-title":"Food Chem Toxicol"},{"issue":"5","key":"3177_CR47","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1007\/s00125-012-2495-3","volume":"55","author":"K Huynh","year":"2012","unstructured":"Huynh K, Kiriazis H, Du XJ, Love JE, Jandeleit-Dahm KA, Forbes JM, McMullen JR, Ritchie RH. Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db\/db mouse model of type 2 diabetes. Diabetologia. 2012;55(5):1544\u201353.","journal-title":"Diabetologia"},{"issue":"6","key":"3177_CR48","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1161\/CIRCRESAHA.117.311401","volume":"122","author":"SJ Forrester","year":"2018","unstructured":"Forrester SJ, Kikuchi DS, Hernandes MS, Xu Q, Griendling KK. Reactive oxygen species in metabolic and inflammatory signaling. Circ Res. 2018;122(6):877\u2013902.","journal-title":"Circ Res"},{"issue":"5","key":"3177_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0177453","volume":"12","author":"C Zgheib","year":"2017","unstructured":"Zgheib C, Hodges MM, Hu J, Liechty KW, Xu J. Long non-coding RNA Lethe regulates hyperglycemia-induced reactive oxygen species production in macrophages. PLoS One. 2017;12(5):e0177453.","journal-title":"PLoS One"},{"issue":"12","key":"3177_CR50","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1038\/sj.emboj.7600244","volume":"23","author":"F Yeung","year":"2004","unstructured":"Yeung F, Hoberg JE, Ramsey CS, et al. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 2004;23(12):2369\u201380.","journal-title":"EMBO J"},{"key":"3177_CR51","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.redox.2018.03.011","volume":"16","author":"SA Manea","year":"2018","unstructured":"Manea SA, Antonescu ML, Fenyo IM, Raicu M, Simionescu M, Manea A. Epigenetic regulation of vascular NADPH oxidase expression and reactive oxygen species production by histone deacetylase-dependent mechanisms in experimental diabetes. Redox Biol. 2018;16:332\u201343.","journal-title":"Redox Biol"},{"issue":"9","key":"3177_CR52","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.bcp.2013.02.015","volume":"85","author":"MJ Zarzuelo","year":"2013","unstructured":"Zarzuelo MJ, L\u00f3pez-Sep\u00falveda R, S\u00e1nchez M, et al. SIRT1 inhibits NADPH oxidase activation and protects endothelial function in the rat aorta: implications for vascular aging. Biochem Pharmacol. 2013;85(9):1288\u201396.","journal-title":"Biochem Pharmacol"},{"issue":"11","key":"3177_CR53","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.jnutbio.2015.06.006","volume":"26","author":"PK Bagul","year":"2015","unstructured":"Bagul PK, Deepthi N, Sultana R, Banerjee SK. Resveratrol ameliorates cardiac oxidative stress in diabetes through deacetylation of NFkB-p65 and histone 3. J Nutr Biochem. 2015;26(11):1298\u2013307.","journal-title":"J Nutr Biochem"},{"key":"3177_CR54","doi-asserted-by":"publisher","first-page":"1737185","DOI":"10.1155\/2016\/1737185","volume":"2016","author":"Z Zeng","year":"2016","unstructured":"Zeng Z, Chen Z, Xu S, et al. Polydatin protecting kidneys against hemorrhagic shock-induced mitochondrial dysfunction via SIRT1 activation and p53 Deacetylation. Oxidative Med Cell Longev. 2016;2016:1737185.","journal-title":"Oxidative Med Cell Longev"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-020-03177-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12906-020-03177-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-020-03177-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,18]],"date-time":"2024-08-18T18:35:00Z","timestamp":1724006100000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-020-03177-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3177"],"URL":"https:\/\/doi.org\/10.1186\/s12906-020-03177-y","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"12 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The protocol for animal use was approved by the Committee on the Ethics of Animal Experiments of Shaanxi University of Chinese Medicine. For consent to participate, not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"378"}}